Tatsuya Yamashita

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 19

Top Topics

Hepatitis C Virus

Helicobacter Pylori Infection

Top Venues

International journal of molecular sciences

Clinical journal of gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Miyabi Miura, Michiko Nishino, Kazunori Kawaguchi, Shihui Li, Tetsuro Shimakami, Toshikatsu Tamai, Hidetoshi Nakagawa, Takeshi Terashima, Noriho Iida, Hajime Takatori, Kuniaki Arai, Yoshio Sakai, Tatsuya Yamashita, Masao Honda, Shuichi Kaneko, Eishiro Mizukoshi, Taro Yamashita
Programmed cell death-1 is involved with peripheral blood immune cell profiles in patients with hepatitis C virus antiviral therapy. PloS one 19 (5) (2024)
Tatsuya Yamashita, Natsumi Suzuki, Katsuaki Motoyoshi, Wanjun Zhu, Junji Furuse
Characteristics of patients with longer treatment period of lenvatinib for unresectable hepatocellular carcinoma: A post-hoc analysis of post-marketing surveillance study in Japan. PloS one 19 (3) (2024)
Miyabi Miura, Michiko Nishino, Kazunori Kawaguchi, Shihui Li, Tetsuro Shimakami, Toshikatsu Tamai, Hidetoshi Nakagawa, Takeshi Terashima, Noriho Iida, Hajime Takatori, Kuniaki Arai, Yoshio Sakai, Tatsuya Yamashita, Masao Honda, Shuichi Kaneko, Eishiro Mizukoshi, Taro Yamashita
Programmed cell death-1 is involved with peripheral blood immune cell profiles in patients with hepatitis C virus antiviral therapy. PloS one 19 (5) (2024)
Miyabi Miura, Michiko Nishino, Kazunori Kawaguchi, Shihui Li, Tetsuro Shimakami, Toshikatsu Tamai, Hidetoshi Nakagawa, Takeshi Terashima, Noriho Iida, Hajime Takatori, Kuniaki Arai, Yoshio Sakai, Tatsuya Yamashita, Masao Honda, Shuichi Kaneko, Eishiro Mizukoshi, Taro Yamashita
Programmed cell death-1 is involved with peripheral blood immune cell profiles in patients with hepatitis C virus antiviral therapy. PloS one 19 (5) (2024)
Tatsuya Yamashita, Natsumi Suzuki, Katsuaki Motoyoshi, Wanjun Zhu, Junji Furuse
Characteristics of patients with longer treatment period of lenvatinib for unresectable hepatocellular carcinoma: A post-hoc analysis of post-marketing surveillance study in Japan. PloS one 19 (3) (2024)
Tatsuya Yamashita, Natsumi Suzuki, Katsuaki Motoyoshi, Wanjun Zhu, Junji Furuse
Characteristics of patients with longer treatment period of lenvatinib for unresectable hepatocellular carcinoma: A post-hoc analysis of post-marketing surveillance study in Japan. PloS one 19 (3) (2024)
Tsuyoshi Suda, Hajime Takatori, Takehiro Hayashi, Kiichiro Kaji, Kouki Nio, Takeshi Terashima, Tetsuro Shimakami, Kuniaki Arai, Tatsuya Yamashita, Eishiro Mizukoshi, Masao Honda, Kenichiro Okumura, Kazuto Kozaka, Taro Yamashita
Plasma Antithrombin III Levels Can Be a Prognostic Factor in Liver Cirrhosis Patients with Portal Vein Thrombosis. International journal of molecular sciences 24 (9) (2023)
Tsuyoshi Suda, Hajime Takatori, Takehiro Hayashi, Kiichiro Kaji, Kouki Nio, Takeshi Terashima, Tetsuro Shimakami, Kuniaki Arai, Tatsuya Yamashita, Eishiro Mizukoshi, Masao Honda, Kenichiro Okumura, Kazuto Kozaka, Taro Yamashita
Plasma Antithrombin III Levels Can Be a Prognostic Factor in Liver Cirrhosis Patients with Portal Vein Thrombosis. International journal of molecular sciences 24 (9) (2023)
Takeshi Terashima, Tatsuya Yamashita, Naoki Takemura, Anri Inaki, Akinori Shimizu, Kenichi Harada, Taro Yamashita, Seigo Kinuya, Keiji Hanada
A case of frequent hypoglycemic attacks successfully controlled with capecitabine plus temozolomide and 177 Lu-DOTATATE peptide receptor radionuclide therapy in a patient with recurrent pancreatic insulinoma. Clinical journal of gastroenterology (2023)
Ru Li, Hikari Okada, Taro Yamashita, Kouki Nio, Han Chen, Yingyi Li, Tetsuro Shimakami, Hajime Takatori, Kuniaki Arai, Yoshio Sakai, Tatsuya Yamashita, Eishiro Mizukoshi, Masao Honda, Shuichi Kaneko
FOXM1 Is a Novel Molecular Target of AFP-Positive Hepatocellular Carcinoma Abrogated by Proteasome Inhibition. International journal of molecular sciences 23 (15) (2022)
Azusa Kitao, Osamu Matsui, Yu Zhang, Takahiro Ogi, Satoko Nakada, Yasunori Sato, Kenichi Harada, Norihide Yoneda, Kazuto Kozaka, Dai Inoue, Kotaro Yoshida, Wataru Koda, Taro Yamashita, Tatsuya Yamashita, Shuichi Kaneko, Satoshi Kobayashi, Toshifumi Gabata
Dynamic CT and Gadoxetic Acid-enhanced MRI Characteristics of P53-mutated Hepatocellular Carcinoma. Radiology (2022)
Tsuyoshi Suda, Taro Yamashita, Hajime Sunagozaka, Hikari Okada, Kouki Nio, Yoshio Sakai, Tatsuya Yamashita, Eishiro Mizukoshi, Masao Honda, Shuichi Kaneko
Dickkopf-1 Promotes Angiogenesis and is a Biomarker for Hepatic Stem Cell-like Hepatocellular Carcinoma. International journal of molecular sciences 23 (5) (2022)
Eishiro Mizukoshi, Hidetoshi Nakagawa, Toshikatsu Tamai, Masaaki Kitahara, Kazumi Fushimi, Kouki Nio, Takeshi Terashima, Noriho Iida, Kuniaki Arai, Tatsuya Yamashita, Taro Yamashita, Yoshio Sakai, Masao Honda, Shuichi Kaneko
Peptide vaccine-treated, long-term surviving cancer patients harbor self-renewing tumor-specific CD8 + T cells. Nature communications 13 (1) (2022)
Han Chen, Kouki Nio, Hong Tang, Taro Yamashita, Hikari Okada, Yingyi Li, Phuong Thi Bich Doan, Ru Li, Junyan Lv, Yoshio Sakai, Tatsuya Yamashita, Eishiro Mizukoshi, Masao Honda, Shuichi Kaneko
BMP9-ID1 Signaling Activates HIF-1α and VEGFA Expression to Promote Tumor Angiogenesis in Hepatocellular Carcinoma. International journal of molecular sciences 23 (3) (2022)
Shihui Li, Eishiro Mizukoshi, Kazunori Kawaguchi, Miyabi Miura, Michiko Nishino, Tetsuro Shimakami, Kuniaki Arai, Taro Yamashita, Yoshio Sakai, Tatsuya Yamashita, Masao Honda, Shuichi Kaneko
Alterations in Hepatocellular Carcinoma-Specific Immune Responses Following Hepatitis C Virus Elimination by Direct-Acting Antivirals. International journal of molecular sciences 23 (19) (2022)
Noriho Iida, Eishiro Mizukoshi, Tatsuya Yamashita, Masahiro Yutani, Jun Seishima, Ziyu Wang, Kuniaki Arai, Hikari Okada, Taro Yamashita, Yoshio Sakai, Yusuke Masuo, Rina Agustina, Yukio Kato, Yukako Fujinaga, Masanobu Oshima, Masao Honda, François Lebreton, Michael S Gilmore, Shuichi Kaneko
Chronic liver disease enables gut Enterococcus faecalis colonization to promote liver carcinogenesis. Nature cancer 2 (10) (2021)
Andrew X Zhu, Richard S Finn, Yoon-Koo Kang, Chia-Jui Yen, Peter R Galle, Josep M Llovet, Eric Assenat, Giovanni Brandi, Kenta Motomura, Izumi Ohno, Bruno Daniele, Arndt Vogel, Tatsuya Yamashita, Chih-Hung Hsu, Guido Gerken, John Bilbruck, Yanzhi Hsu, Kun Liang, Ryan C Widau, Chunxiao Wang, Paolo Abada, Masatoshi Kudo
Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab. British journal of cancer 124 (8) (2021)
Tsuyoshi Suda, Hajime Takatori, Takehiro Hayashi, Rika Horii, Kouki Nio, Takeshi Terashima, Noriho Iida, Masaaki Kitahara, Tetsuro Shimakami, Kuniaki Arai, Taro Yamashita, Tatsuya Yamashita, Eishiro Mizukoshi, Masao Honda, Kenichiro Okumura, Kazuto Kozaka, Shuichi Kaneko
Investigation of Thrombosis Volume, Anticoagulants, and Recurrence Factors in Portal Vein Thrombosis with Cirrhosis. Life (Basel, Switzerland) 10 (9) (2020)
Yoshio Sakai, Shinya Fukunishi, Masayuki Takamura, Oto Inoue, Shinichiro Takashima, Soichiro Usui, Akihiro Seki, Alessandro Nasti, Tuyen Thuy Bich Ho, Kazunori Kawaguchi, Akira Asai, Yusuke Tsuchimoto, Taro Yamashita, Tatsuya Yamashita, Eishiro Mizukoshi, Masao Honda, Yasuhito Imai, Kenichi Yoshimura, Toshinori Murayama, Takashi Wada, Ken-Ichi Harada, Kazuhide Higuchi, Shuichi Kaneko
Regenerative Therapy for Liver Cirrhosis Based on Intrahepatic Arterial Infusion of Autologous Subcutaneous Adipose Tissue-Derived Regenerative (Stem) Cells: Protocol for a Confirmatory Multicenter Uncontrolled Clinical Trial. JMIR research protocols 9 (3) (2020)